Literature DB >> 14700742

Temporal lobe pathology of human patients with neurofilament inclusion disease.

N J Cairns1, E Jaros, R H Perry, R A Armstrong.   

Abstract

Neurofilament inclusion disease (NID) is a novel neurodegenerative disease characterized histologically by the presence of neurofilament positive neuronal inclusions (NI) and swollen achromatic neurons (SN). The density and distribution of NI and SN were studied in areas of the temporal lobe in four cases of NID. In NID, the density of the NI and SN was greater in areas of the cerebral cortex compared with the hippocampus and dentate gyrus. Lesion densities were similar in the different gyri of the temporal cortex and in the various cornu ammonis sectors of the hippocampus. In the cerebral cortex, the density of the NI and SN was greater in the lower compared with the upper cortical laminae. There was no significant correlation between the densities of the NI and SN. The distribution of the temporal lobe pathology of NID has several differences from that reported in Pick's disease and corticobasal degeneration supporting the hypothesis that NID is a novel and unique type of neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14700742     DOI: 10.1016/j.neulet.2003.10.020

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID): a study using alpha-internexin immunohistochemistry and principal components analysis (PCA).

Authors:  R A Armstrong; E Kerty; K Skullerud; N J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

2.  Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2015-05-01       Impact factor: 3.575

3.  Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID).

Authors:  Richard A Armstrong; Marla Gearing; Eileen H Bigio; Felix F Cruz-Sanchez; Charles Duyckaerts; Ian R A Mackenzie; Robert H Perry; Kari Skullerud; Hideaki Yokoo; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2011-07-27       Impact factor: 3.575

4.  The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease.

Authors:  Richard A Armstrong; Marla Gearing; Eileen H Bigio; Felix F Cruz-Sanchez; Charles Duyckaerts; Ian R A Mackenzie; Robert H Perry; Kari Skullerud; Hedeaki Yokoo; Nigel J Cairns
Journal:  Acta Neuropathol       Date:  2010-10-01       Impact factor: 17.088

5.  Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an alpha-internexin immunohistochemical study.

Authors:  R A Armstrong; N J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2006-11-17       Impact factor: 3.575

6.  Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders.

Authors:  Richard A Armstrong; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2012-06-08       Impact factor: 3.575

7.  Prion-like transmission of α-synuclein pathology in the context of an NFL null background.

Authors:  Nicola J Rutherford; Mieu Brooks; Cara J Riffe; Kimberly-Marie M Gorion; Jasie K Howard; Jess-Karan S Dhillon; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2017-09-28       Impact factor: 3.046

8.  Novel antibodies to phosphorylated α-synuclein serine 129 and NFL serine 473 demonstrate the close molecular homology of these epitopes.

Authors:  Nicola J Rutherford; Mieu Brooks; Benoit I Giasson
Journal:  Acta Neuropathol Commun       Date:  2016-08-08       Impact factor: 7.801

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.